Related Experiment Video
Updated: Jul 15, 2026
08:30
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Pediatric DXA: clinical applications.
Larry A Binkovitz1, Paul Sparke, Maria J Henwood
1Department of Radiology, Columbus Children's Hospital, 700 Childrens Way, Columbus, OH, USA. binkovitz@yahoo.com
Pediatric Radiology
|April 14, 2007
Summary
Pediatric bone mineral density (BMD) assessment using DXA is crucial for preventing adult osteoporosis. This review aids clinicians in interpreting DXA scans for children, highlighting factors affecting bone health.
Area of Science:
- Pediatric Endocrinology
- Bone Metabolism
- Radiology
Background:
- Normal bone accrual depends on nutrition, vitamin D activation, hormones, and mechanical stress.
- Genetic/acquired diseases and treatments can negatively impact pediatric bone health.
- Childhood bone mass is critical for preventing adult osteoporosis.
Purpose of the Study:
- To review research on bone mineral density (BMD) in children.
- To guide radiologists and clinicians in utilizing and interpreting DXA scans in pediatric populations.
Main Methods:
- Review of previous research on pediatric BMD.
- Focus on the clinical application and interpretation of Dual-energy X-ray Absorptiometry (DXA).
Main Results:
- Increased awareness of childhood bone mass accrual's importance.
- Growing utilization of DXA in pediatrics due to research and new therapies.
- Availability of bisphosphonates for improving BMD.
Conclusions:
- DXA is increasingly used in pediatrics for bone mineral density assessment.
- This review provides essential information for DXA utilization and interpretation in children.
- Understanding pediatric BMD is key for long-term skeletal health and osteoporosis prevention.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...